Detalhe da pesquisa
1.
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial.
BMC Infect Dis
; 24(1): 89, 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38225598
2.
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV).
J Infect Dis
; 228(10): 1318-1325, 2023 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470445
3.
Asymptomatic Natural Human Infections With the Simian Malaria Parasites Plasmodium cynomolgi and Plasmodium knowlesi.
J Infect Dis
; 219(5): 695-702, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30295822
4.
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial.
Lancet Infect Dis
; 24(1): 36-45, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37778363
5.
Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial.
Lancet Infect Dis
; 23(1): 81-90, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36174595
6.
Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria.
EBioMedicine
; 96: 104805, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37757570
7.
Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries.
PLoS One
; 17(12): e0278928, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36525403